Serum levels of the IL-33 decoy receptor soluble ST2; a possible prognostic marker in clear-cell renal cell carcinoma

by H.H. Aarstad, G. Gudbrandsdottir, K.M. Hjelle, T.H.A. Tvedt, Ø. Bruserud, L. Bostad, H.J. Aarstad, C. Beisland
Published 2020-07-01

SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

by M.M.O. Barros, A. Röth, W. Barcellini, T.H.A. Tvedt, Y. Miyakawa, D.J. Kuter, W. Hobbs, J. Su, X. Jiang, J.M. Arias, I.C. Weitz
Published 2020-11-01